Galectin Therapeutics Issued Patent for PF Therapy Candidate GR-MD-02

  • Research and Development

    Galectin Therapeutics Issued Patent for PF Therapy Candidate GR-MD-02

    Posted by Pulmonary Fibrosis News Moderator on July 10, 2018 at 1:13 pm

    Galectin Therapeutics has been issued a patent for its lead investigative therapy GR-MD-02 for the treatment of pulmonary fibrosis by the U.S. Patent and Trademark Office. Click here to read more.

    Do you know anything about Galectin Therapeutics or any of their treatments? What are your thoughts on this news?

    replied 6 years, 4 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .